Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18642,146,0.95 [0.81-1.10],0.4827372151177455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19603,203,1.00 [0.88-1.14],0.9825428745352844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19376,1411,1.03 [0.98-1.08],0.3180876524129618
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Candidiasis,19617,444,1.00 [0.92-1.09],0.9644304990723146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18969,3450,1.01 [0.98-1.05],0.4033188879561938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18951,3505,1.00 [0.97-1.03],0.8344226952126718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19372,1159,1.02 [0.97-1.08],0.4599144230250593
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19530,107,0.97 [0.81-1.16],0.7569582689888911
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17304,1025,0.98 [0.93-1.04],0.554644029287052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16669,1234,0.99 [0.94-1.05],0.7758823533248262
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16332,268,1.01 [0.90-1.13],0.9109863420282398
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12770,2215,0.98 [0.94-1.02],0.3055176521914186
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16279,392,1.06 [0.97-1.17],0.2108730821234541
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19585,1372,1.01 [0.96-1.07],0.6037698592265044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,19687,514,1.00 [0.92-1.09],0.9987120556226786
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18962,997,1.02 [0.96-1.08],0.547053540580531
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19629,1133,0.98 [0.92-1.03],0.3810794265356645
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18416,203,1.00 [0.88-1.14],0.949090461313228
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19738,51,1.09 [0.83-1.41],0.5423817737043
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,19485,989,0.98 [0.92-1.04],0.5173380940548011
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19488,65,1.05 [0.83-1.32],0.7027503029955757
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,19683,112,1.16 [0.97-1.40],0.1011548451479491
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19668,97,1.19 [0.98-1.45],0.078700187021379
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18352,387,1.04 [0.95-1.15],0.4094372305214849
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18216,251,1.01 [0.89-1.13],0.931289503011028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18315,102,1.14 [0.94-1.37],0.1830041844480774
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19723,47,0.89 [0.68-1.17],0.4142116348621076
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19677,146,1.07 [0.91-1.25],0.4232932392736755
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral warts,19579,48,1.41 [1.06-1.88],0.017679457406683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19602,71,0.97 [0.77-1.21],0.7554899950282635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,19498,221,0.88 [0.78-0.99],0.0332393580282971
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19667,38,0.89 [0.66-1.19],0.4187943733085217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19650,38,0.93 [0.69-1.26],0.6497854529899814
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9326,67,0.90 [0.72-1.12],0.3484794380863151
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19349,1413,0.98 [0.93-1.03],0.3950745238317562
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of meninges,19725,57,1.01 [0.78-1.30],0.9453630156930592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19658,71,1.06 [0.85-1.33],0.6103098451738347
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19716,101,0.98 [0.82-1.19],0.8658509783139319
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of ovary,10362,65,1.04 [0.82-1.31],0.7687072002916691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Ascending colon,19703,380,0.97 [0.89-1.07],0.5920251094731454
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Caecum,19715,326,0.97 [0.88-1.08],0.6096284750292214
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19612,76,0.89 [0.72-1.09],0.2495745972009431
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Descending colon,19702,218,1.00 [0.88-1.14],0.9975932173070542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,19659,341,0.93 [0.84-1.03],0.1599544895968486
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19609,594,1.00 [0.92-1.08],0.9495141568435892
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Transverse colon,19694,449,1.01 [0.92-1.10],0.8588978693642202
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Carcinoma in situ of breast,7807,44,0.83 [0.63-1.09],0.1796710477444648
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7840,54,1.01 [0.78-1.31],0.9349753420287658
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14149,63,0.92 [0.73-1.16],0.4750374497413959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14169,83,1.00 [0.82-1.23],0.963437229945829
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19687,109,0.86 [0.72-1.03],0.0935969030122191
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",19688,106,0.87 [0.73-1.04],0.1247154450062364
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,10128,146,0.95 [0.81-1.11],0.508928557989361
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lung cancer and mesothelioma,12580,421,0.97 [0.88-1.06],0.4501776522773154
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lymphoid leukaemia,14149,63,0.92 [0.73-1.15],0.4528205706640681
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14272,186,1.15 [1.00-1.32],0.0527804411496921
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14339,253,0.98 [0.87-1.10],0.7357158112383226
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7921,97,0.87 [0.72-1.05],0.1365305629756906
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14181,95,1.03 [0.85-1.25],0.7591045479301846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14210,124,1.06 [0.90-1.26],0.47950217018322
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14197,111,0.91 [0.76-1.08],0.2656539868870677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7902,78,0.92 [0.75-1.14],0.4558244146671302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14194,108,0.98 [0.82-1.17],0.8282219197532192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7068,806,0.93 [0.88-1.00],0.0377267484346839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14197,111,0.85 [0.72-1.01],0.0605055611103538
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14167,81,1.03 [0.83-1.26],0.8113356615146738
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14204,118,1.01 [0.85-1.20],0.9154732932797808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,19612,159,1.12 [0.96-1.30],0.1512714922957342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of trunk,19715,66,1.34 [1.05-1.71],0.0188668182661365
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanoma in situ,14132,98,1.07 [0.88-1.29],0.5009334549330677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14190,104,1.00 [0.83-1.20],0.9887044292242386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14257,171,0.98 [0.85-1.13],0.8120507922739217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14380,294,0.87 [0.79-0.97],0.0107117759235182
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14197,111,1.01 [0.85-1.21],0.8766371740052081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,19595,143,0.94 [0.80-1.09],0.4152123938802954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15330,1244,0.96 [0.91-1.01],0.1215592837637841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15396,1310,0.97 [0.92-1.02],0.2460184782985103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19483,319,0.93 [0.84-1.03],0.1733097710035322
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17834,105,1.09 [0.91-1.31],0.3718215305466015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19223,59,1.08 [0.84-1.38],0.5515022532355525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19124,2881,1.02 [0.98-1.05],0.3080846454127443
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18330,60,1.56 [1.21-2.03],0.0007834737201241
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19352,60,1.06 [0.83-1.35],0.6400682357639357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19337,1608,1.02 [0.97-1.07],0.3886888620638372
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19335,1606,1.02 [0.97-1.07],0.4240230760555827
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17822,93,0.91 [0.76-1.11],0.3538531110856022
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19438,1168,1.13 [1.06-1.19],3.367373417451332e-05
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19390,98,0.96 [0.80-1.16],0.6738723447232252
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19223,59,0.94 [0.74-1.20],0.6310382493285323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19231,67,0.99 [0.79-1.24],0.9489211135976192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19586,294,0.83 [0.75-0.92],0.0005637695461569
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19632,32,0.93 [0.67-1.29],0.6577553219421178
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19530,238,0.75 [0.66-0.84],5.90281936724667e-07
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18380,110,1.10 [0.92-1.32],0.2914973062207054
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13397,329,0.95 [0.86-1.05],0.3413308691750866
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18476,85,1.05 [0.85-1.30],0.6281994002793514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18481,90,1.03 [0.84-1.25],0.8036873403510015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13130,62,1.03 [0.82-1.31],0.7888375207647141
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18390,42,0.90 [0.68-1.18],0.441578042040725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17768,266,0.93 [0.84-1.05],0.2354684220068019
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19097,747,0.94 [0.88-1.00],0.0599891142459618
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18757,407,0.93 [0.85-1.02],0.1233989302286093
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18495,145,1.04 [0.89-1.21],0.628054625606725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19515,1167,1.07 [1.02-1.13],0.0127033322898713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16709,1137,1.08 [1.02-1.14],0.0112829913321302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13132,64,0.89 [0.71-1.12],0.3296536841786778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17829,84,1.09 [0.89-1.34],0.4035700772980574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13368,300,1.01 [0.91-1.12],0.8874850087346793
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13115,47,1.14 [0.86-1.51],0.351008474892883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16886,3818,1.02 [0.99-1.05],0.1659912192228603
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13292,224,0.94 [0.83-1.06],0.3285320108099103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13650,582,1.00 [0.93-1.08],0.931667645136564
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19692,302,1.05 [0.94-1.16],0.4179132545657436
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19512,122,0.90 [0.76-1.06],0.2159752742817239
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13189,121,0.97 [0.82-1.15],0.7607080808946383
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13136,68,0.96 [0.77-1.21],0.740140274940748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19198,1453,1.01 [0.96-1.06],0.791576423032307
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13380,312,0.98 [0.88-1.09],0.7300164265594298
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13389,321,0.92 [0.83-1.02],0.1001257417988656
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13781,713,1.06 [0.99-1.13],0.1208479195639022
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13195,127,0.92 [0.78-1.08],0.2858369362645051
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19507,117,0.90 [0.76-1.06],0.2102817385401013
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13817,749,1.02 [0.95-1.09],0.5913426816914288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13600,532,0.99 [0.91-1.07],0.7489445025757904
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17560,58,1.05 [0.82-1.35],0.6840403243191526
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18427,5359,1.01 [0.98-1.03],0.5672409394341816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17793,48,0.96 [0.74-1.26],0.7814992797659588
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17791,46,0.99 [0.75-1.31],0.9607348524947734
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19594,1554,1.00 [0.95-1.05],0.8994777298492495
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19592,1552,1.00 [0.95-1.05],0.9667681989680634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17800,55,1.04 [0.81-1.34],0.7661771207490903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19436,957,1.02 [0.96-1.08],0.6167158413260284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14898,1830,0.98 [0.94-1.03],0.4344047047531807
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19727,241,0.93 [0.82-1.04],0.2034394193179248
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18442,92,0.93 [0.77-1.12],0.4420038703126835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18577,98,1.00 [0.83-1.21],0.9920593645409652
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18623,144,1.12 [0.95-1.32],0.1650880339426729
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13233,165,0.97 [0.84-1.12],0.7055984643964075
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17388,156,1.01 [0.87-1.17],0.8985539658101797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2109,80,1.01 [0.81-1.25],0.945364914529922
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2242,246,0.96 [0.85-1.08],0.5191475952089024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17300,68,1.06 [0.84-1.33],0.615937256634743
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2075,47,0.76 [0.58-0.98],0.0357981874953311
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19045,1813,1.04 [0.99-1.08],0.0996827956985124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18853,503,0.88 [0.82-0.96],0.0028168536651335
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17871,369,0.97 [0.88-1.06],0.4915452562136601
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13953,885,1.00 [0.94-1.07],0.961431693939632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19621,261,0.86 [0.77-0.96],0.0086584388816452
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18507,229,0.93 [0.82-1.04],0.206229691105194
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,17119,1284,1.00 [0.95-1.05],0.9259500218956016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Aortic aneurysm,18592,314,0.92 [0.83-1.02],0.098488628101281
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18345,67,1.08 [0.86-1.36],0.4937342638225224
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18508,230,1.03 [0.91-1.17],0.6052992274410949
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10089,2370,0.95 [0.91-0.99],0.0075945821037155
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,AV-block,15107,555,0.98 [0.90-1.06],0.5988901880101876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19668,467,0.97 [0.89-1.06],0.4918123098530932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiac arrest,7940,221,1.05 [0.93-1.19],0.4142747679939639
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,14722,170,0.86 [0.75-0.99],0.035201461395992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14640,88,1.04 [0.86-1.27],0.6734533205556372
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19732,61,1.07 [0.84-1.36],0.5834737587562162
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,15839,1287,0.98 [0.93-1.04],0.5557482759969835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18121,2308,0.99 [0.95-1.03],0.609065149537787
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16002,7596,0.99 [0.97-1.01],0.4864809807156688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,18411,287,0.89 [0.80-0.99],0.0313566711405744
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Endocarditis,14628,76,1.05 [0.85-1.31],0.6364505430111131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",19496,1373,1.01 [0.96-1.07],0.5760907733421277
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,17043,6706,1.01 [0.98-1.03],0.5414087930432776
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",17047,6710,1.01 [0.98-1.03],0.5357398427148945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, portal",19595,86,0.81 [0.67-0.98],0.0288602658065454
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10576,239,1.03 [0.91-1.16],0.6592763285047805
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10464,127,1.02 [0.87-1.21],0.7909296915623691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,19587,1314,1.01 [0.96-1.07],0.6244232100135514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18667,123,0.88 [0.75-1.04],0.1376167827541841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18269,2434,0.99 [0.96-1.03],0.679676177722534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19315,664,1.04 [0.97-1.12],0.2532672862411489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Left bundle-branch block,14977,425,0.97 [0.89-1.06],0.546674128953949
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19185,894,1.00 [0.94-1.07],0.9519039021772204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16602,767,1.02 [0.95-1.09],0.6185463767656377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19624,164,1.11 [0.96-1.29],0.1519959356895144
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19700,338,0.98 [0.89-1.09],0.7229683790129168
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Oesophageal varices,18182,58,0.84 [0.66-1.06],0.1444444759647033
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other aneurysm,18366,88,1.12 [0.91-1.37],0.2805904979535706
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,15045,493,1.00 [0.92-1.09],0.9987570982675203
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18387,109,1.05 [0.88-1.25],0.5996520913204288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18546,268,1.00 [0.89-1.12],0.9540188085398552
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14743,191,1.07 [0.93-1.23],0.3327308733300669
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other disorders of veins,18213,89,1.16 [0.95-1.43],0.151247217223273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18163,39,1.12 [0.83-1.52],0.4641114248393935
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18055,71,1.05 [0.84-1.32],0.6678801177814282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18264,140,1.03 [0.88-1.21],0.7314872187677492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15737,1185,0.97 [0.92-1.02],0.257402729618651
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18323,50,0.93 [0.72-1.20],0.5609004722479622
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18881,603,0.98 [0.91-1.06],0.6779992578584835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19091,461,0.99 [0.91-1.08],0.8588436943427478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18780,796,1.01 [0.94-1.07],0.8746221880710836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8063,344,0.96 [0.87-1.06],0.4102611661521417
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,18734,489,1.00 [0.92-1.09],0.9195115630421188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18483,359,0.89 [0.81-0.98],0.0208956928119249
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,19124,494,0.95 [0.87-1.03],0.1869288080761429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19653,802,0.97 [0.91-1.03],0.3504876255052881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Right bundle-branch block,14983,431,0.99 [0.90-1.08],0.7674637688971111
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,19086,456,0.99 [0.91-1.08],0.8327194340415854
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18193,209,0.99 [0.87-1.12],0.8415136890128178
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19299,755,1.03 [0.96-1.10],0.4101357790090468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19288,787,1.03 [0.96-1.10],0.3780422099440698
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18642,50,0.98 [0.75-1.27],0.8621136140528215
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18358,80,0.93 [0.76-1.14],0.466828676574621
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,18916,265,1.11 [0.98-1.24],0.090848162933244
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18570,279,1.00 [0.89-1.11],0.9497211128257468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,18557,433,1.04 [0.95-1.14],0.4280842469889505
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18293,97,0.85 [0.71-1.02],0.0900170375745568
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,19496,783,0.93 [0.87-0.99],0.0312619929381773
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19669,279,1.04 [0.93-1.16],0.5379634904111151
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16975,1168,1.02 [0.97-1.08],0.3896892539152357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,19300,3493,1.01 [0.98-1.04],0.6145015302859715
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19644,328,1.00 [0.90-1.11],0.9868732307972572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16992,1185,1.07 [1.01-1.13],0.0163733450500661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15872,65,0.99 [0.79-1.25],0.954261325822952
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,19305,979,1.01 [0.95-1.07],0.6918307091861297
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17016,1209,1.00 [0.95-1.06],0.8781946132558895
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Vascular dementia,19031,192,0.92 [0.81-1.05],0.225626729949715
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Alzheimer disease,19735,502,0.94 [0.87-1.02],0.1632502331009686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12316,95,1.00 [0.83-1.21],0.9977994204377076
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Bell's palsy,18196,71,1.11 [0.88-1.39],0.3697249268091439
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18548,423,1.05 [0.96-1.15],0.2799154023710782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral cysts,19368,202,1.00 [0.88-1.14],0.9712475193901664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19675,326,0.93 [0.84-1.03],0.1574002573055959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19040,72,1.07 [0.86-1.34],0.5336195114857523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19720,61,0.83 [0.66-1.05],0.1229068123277169
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19234,68,1.01 [0.81-1.27],0.924865774674604
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,18493,246,0.94 [0.83-1.05],0.2804482605977431
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19353,1106,1.02 [0.96-1.08],0.4831456717408664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19686,531,0.94 [0.87-1.02],0.1568375111510984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,19184,2814,0.95 [0.92-0.98],0.0023560324698373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Generalized epilepsy,19427,43,1.23 [0.92-1.64],0.1716346886232986
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,19614,265,0.98 [0.88-1.10],0.7541671080292518
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hydrocephalus,19226,60,0.91 [0.72-1.15],0.4190858400501246
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19724,56,0.99 [0.77-1.28],0.9620566307609534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18186,61,0.83 [0.66-1.04],0.1111111395126218
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18186,61,0.98 [0.77-1.24],0.8393651654874109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Memory loss,18820,133,0.97 [0.83-1.14],0.7229169042829255
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,18480,233,1.07 [0.94-1.21],0.287636827138749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19693,212,1.06 [0.93-1.21],0.3604346433070396
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Motor neuron disease,12409,166,1.00 [0.87-1.16],0.9908611584903552
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19631,52,1.02 [0.79-1.32],0.8776908108105659
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19147,1022,1.02 [0.96-1.08],0.5163104075381524
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,18502,3505,0.99 [0.96-1.03],0.6745212751183258
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19210,242,0.96 [0.85-1.07],0.4482726896854957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18461,336,1.02 [0.92-1.13],0.685674198392342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19671,290,1.01 [0.91-1.13],0.8210380073562701
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14990,806,0.97 [0.91-1.03],0.3135729901028087
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19233,67,0.89 [0.71-1.11],0.2965744759987873
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other disorders of nervous system,19298,132,0.90 [0.77-1.05],0.1950655125138196
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19332,177,0.99 [0.86-1.14],0.9321583777056044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other facial nerve disorders,18203,78,1.07 [0.86-1.33],0.5338202421871163
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other headache syndromes,18293,46,1.00 [0.75-1.31],0.9747143088379406
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,19642,476,0.97 [0.89-1.06],0.5323757303226822
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,18662,415,1.00 [0.92-1.10],0.939819289352177
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Parkinson's disease,19704,333,0.91 [0.82-1.00],0.0585715564718499
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19206,40,1.08 [0.80-1.46],0.6210358554133539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Restless leg syndrome,19734,77,0.97 [0.79-1.20],0.8040785612257171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,19553,359,1.01 [0.92-1.12],0.7800011085448961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Small fibre neuropathy,19432,51,0.99 [0.77-1.29],0.9595730821437743
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19723,185,0.99 [0.86-1.13],0.8615487024559241
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18184,59,1.10 [0.86-1.41],0.4399145479622881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19735,507,0.94 [0.87-1.02],0.1506670693047226
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18975,186,0.92 [0.80-1.05],0.2005925305489417
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19206,124,1.00 [0.85-1.19],0.9642081920744774
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19363,470,0.93 [0.86-1.02],0.1132902026652617
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19540,217,0.95 [0.84-1.08],0.4081743472191881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18683,59,0.97 [0.76-1.23],0.7841898484588457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18658,34,1.40 [0.99-1.97],0.0561789071424114
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19632,63,1.25 [0.98-1.60],0.0717209359320418
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19466,186,0.95 [0.83-1.09],0.4508785726249795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2079,50,0.76 [0.59-0.98],0.0377842004673311
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2545,92,0.97 [0.80-1.19],0.7965427416027133
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19172,90,1.14 [0.93-1.40],0.1948702965777034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19501,1201,1.02 [0.97-1.08],0.4796695474683081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19378,754,0.99 [0.93-1.06],0.7858067732835625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18878,254,1.05 [0.94-1.19],0.3937324736375301
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19678,785,0.94 [0.88-1.01],0.0734279653067555
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19730,67,1.24 [0.98-1.57],0.0792426034664778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19626,733,0.94 [0.88-1.01],0.0714843764535663
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19700,420,0.97 [0.89-1.06],0.5404910493521335
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19631,195,1.02 [0.89-1.16],0.8014443176005019
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18714,90,1.16 [0.94-1.42],0.1620907577707422
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18714,90,0.96 [0.79-1.16],0.6745237699896176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18689,65,1.10 [0.87-1.40],0.4138354831622357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19619,855,0.95 [0.89-1.02],0.1364117663872795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18997,233,0.92 [0.82-1.04],0.1742802228296555
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18951,58,0.79 [0.62-0.99],0.0435718178321889
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19390,110,0.91 [0.77-1.09],0.31118812977654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19602,322,0.97 [0.87-1.07],0.5408023869857848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19078,185,0.95 [0.83-1.09],0.4807622834670879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19556,120,0.97 [0.82-1.15],0.7384638835412648
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19320,556,0.97 [0.89-1.04],0.3850733922982481
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19218,136,1.00 [0.85-1.17],0.961285851532741
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17674,2749,1.00 [0.97-1.04],0.7895895470809751
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19565,285,0.96 [0.86-1.07],0.4258062519472018
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19721,157,1.02 [0.88-1.18],0.8287614189878357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19094,470,0.97 [0.89-1.06],0.5590911634288791
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19362,82,0.93 [0.76-1.14],0.4808257284797987
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19722,59,1.20 [0.94-1.55],0.146542225521257
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18731,107,0.86 [0.72-1.03],0.0979683367227584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18778,154,0.85 [0.73-0.98],0.0300970515551286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18442,142,1.14 [0.97-1.33],0.1181438916131477
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18938,45,0.80 [0.61-1.04],0.0976114134981752
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18365,65,0.85 [0.68-1.06],0.1403546659787302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18864,100,0.85 [0.71-1.02],0.0800308782089672
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19009,245,0.99 [0.88-1.11],0.8451938956622091
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18758,134,1.02 [0.87-1.20],0.8027048494348539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18381,81,1.25 [1.01-1.56],0.0419907689750887
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18405,105,1.01 [0.84-1.21],0.9563247697127614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17203,2278,0.98 [0.94-1.02],0.251198064953987
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18706,82,1.11 [0.90-1.37],0.3324268171259582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19501,419,1.07 [0.97-1.17],0.1768552172869762
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19150,68,1.22 [0.96-1.54],0.0975206796273113
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19241,159,0.99 [0.86-1.15],0.9191259184854332
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19538,97,0.86 [0.72-1.04],0.1236562271556514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19698,118,1.00 [0.84-1.18],0.9703076218666932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19623,95,1.16 [0.95-1.41],0.1417943808487851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19499,58,1.02 [0.80-1.30],0.8820440734464353
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19499,58,1.10 [0.86-1.41],0.4566429098003416
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19641,1010,1.01 [0.95-1.07],0.7097435852031793
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19400,769,1.03 [0.96-1.10],0.3999471474048857
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18755,124,0.86 [0.73-1.01],0.0583788617273711
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18708,77,1.15 [0.92-1.43],0.2096196731504572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute pharyngitis,19568,51,0.96 [0.74-1.24],0.7641777361361752
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19668,151,0.97 [0.83-1.13],0.6762460411871634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19567,50,0.94 [0.73-1.22],0.6372189555157353
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza,17515,129,1.05 [0.89-1.24],0.5592131813561432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17512,126,1.07 [0.91-1.27],0.4072169770585143
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic asthma (mode),12244,85,1.24 [1.00-1.52],0.0463166156756252
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic rhinitis,19649,197,1.04 [0.91-1.19],0.5618555760159973
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13324,1483,1.06 [1.01-1.11],0.020455042627343
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13624,1465,1.05 [1.00-1.11],0.0418905121177863
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19297,151,1.11 [0.95-1.29],0.203065236958313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17472,86,1.11 [0.90-1.36],0.3308095467218356
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bronchiectasis,16529,436,1.13 [1.03-1.24],0.0084722824307594
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16155,62,1.30 [1.02-1.67],0.0367970593987475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18779,2686,1.04 [1.01-1.08],0.0174446301278828
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18695,63,0.96 [0.76-1.21],0.704021173608633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,18744,112,0.99 [0.83-1.18],0.9067015616737684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19486,1362,1.01 [0.96-1.06],0.7378968073097265
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,18702,70,0.94 [0.76-1.18],0.6075333234213771
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17903,5135,1.03 [1.00-1.05],0.0392090943689016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18926,294,1.00 [0.89-1.11],0.9478276979185624
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,18223,99,0.94 [0.79-1.14],0.5464208907757369
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Emphysema,16466,373,1.05 [0.95-1.16],0.3074043082692864
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18607,406,1.04 [0.95-1.15],0.36480925473806
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,19511,2125,1.01 [0.97-1.05],0.6725410692136138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,18642,441,1.06 [0.97-1.16],0.1992448482495435
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Later onset COPD,19275,1263,1.01 [0.96-1.07],0.5928141815402432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19719,382,1.04 [0.95-1.15],0.3900493990265666
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,18718,86,0.96 [0.79-1.17],0.6860664660400637
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19491,1069,1.01 [0.96-1.07],0.6433306241497708
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,19491,2251,1.02 [0.98-1.06],0.2533110859325286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19270,638,1.01 [0.94-1.09],0.8099419370728851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other pleural conditions,17293,53,0.77 [0.60-0.98],0.0324112757960431
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19619,515,1.04 [0.96-1.13],0.3587798266843202
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19625,1449,1.05 [1.00-1.10],0.057447101719056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,18359,1119,1.00 [0.95-1.06],0.9825854349206664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural plaque,17457,217,1.01 [0.89-1.14],0.9142247419394856
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19270,1884,1.00 [0.96-1.05],0.8192260820510475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19623,286,1.05 [0.94-1.18],0.3702451301644593
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumothorax,17392,152,0.90 [0.78-1.04],0.153935155790526
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pollen allergy,19726,165,1.09 [0.94-1.27],0.2500250493914622
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pulmonary oedema,19177,73,0.84 [0.68-1.03],0.0913779074610334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Respiratory insufficiency,12220,61,1.34 [1.04-1.73],0.0252364823378402
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19476,1054,1.01 [0.96-1.07],0.6758685732132167
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18830,198,1.04 [0.91-1.19],0.5318296344686245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Viral pneumonia,17629,243,0.99 [0.88-1.12],0.9034891908093706
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19308,194,0.97 [0.85-1.11],0.6251984008726246
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6370,101,1.04 [0.86-1.26],0.6670251455995364
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12627,52,1.07 [0.82-1.40],0.6149833489575094
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,19633,108,0.94 [0.79-1.12],0.5179770141424216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute gastritis,13814,85,1.12 [0.91-1.38],0.2666444752668127
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,18032,166,1.05 [0.91-1.22],0.5084226488495457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute peritonitis,19333,91,0.99 [0.82-1.20],0.9167249060939352
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Alcoholic liver disease,18911,50,0.81 [0.63-1.03],0.0907247578605148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Barrett oesophagus,14156,427,1.02 [0.93-1.12],0.6613913338380354
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17988,122,1.11 [0.93-1.32],0.2447609239580955
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19382,122,1.10 [0.93-1.31],0.2606241796640808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,18049,183,0.96 [0.83-1.09],0.5069115793346147
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,18750,884,1.02 [0.96-1.08],0.5677495825914868
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,14019,290,0.98 [0.88-1.10],0.74041245212873
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic pancreatitis,17912,46,0.97 [0.74-1.27],0.8349074571181679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19619,110,0.88 [0.74-1.05],0.1586500621309479
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,18287,101,1.07 [0.89-1.29],0.4737774775669574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Collagenous colitis,18242,86,0.90 [0.74-1.10],0.3063121175989677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19636,141,0.95 [0.81-1.11],0.5171193529574755
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,19497,1741,0.99 [0.94-1.03],0.5299832938723514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,18224,68,1.08 [0.86-1.36],0.5239827436993565
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19435,52,1.02 [0.78-1.32],0.9001179701379527
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,18219,63,1.07 [0.85-1.36],0.5584421171536313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,19208,155,0.98 [0.85-1.14],0.8119472656258038
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17090,2158,0.99 [0.96-1.04],0.7830118045784821
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,19657,132,0.94 [0.80-1.10],0.4520277363203181
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,19633,772,0.98 [0.92-1.05],0.6195579308843386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17587,3858,1.01 [0.98-1.04],0.605483111025448
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19449,396,0.99 [0.90-1.09],0.8669684602673613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,19666,424,0.99 [0.90-1.08],0.785455148139971
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19128,75,0.90 [0.73-1.11],0.3050094694826794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of salivary glands,19026,47,0.93 [0.71-1.22],0.5988649286407375
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,19463,1277,0.96 [0.91-1.01],0.1432978647321936
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of tongue,19034,77,1.03 [0.83-1.27],0.7867881802394956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19147,1281,1.03 [0.97-1.08],0.3362494954373028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15775,3200,0.97 [0.94-1.00],0.0638627223400581
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,13933,204,1.05 [0.92-1.20],0.4953760303610806
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19650,164,1.11 [0.95-1.29],0.1756343435099455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19710,18,1.22 [0.78-1.93],0.3855692389569839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18989,128,0.90 [0.77-1.06],0.1991283486820247
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12667,92,1.06 [0.87-1.29],0.5477664108526257
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,14212,483,1.05 [0.96-1.14],0.2812362924992498
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,14080,351,1.02 [0.92-1.13],0.6794058644207407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15963,2234,1.00 [0.96-1.04],0.9351843547089772
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14266,537,1.02 [0.94-1.11],0.5945155225106966
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14327,6965,1.00 [0.98-1.02],0.8464902697948631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,19239,1053,0.95 [0.90-1.01],0.0820089769755238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19097,44,0.98 [0.74-1.29],0.8622529074848477
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13410,998,0.94 [0.88-0.99],0.0259736811488736
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18919,58,0.75 [0.59-0.94],0.012197479328064
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,17999,3067,1.00 [0.97-1.04],0.8152658424866971
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,19711,17,1.32 [0.82-2.13],0.2548790329822429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impaction of intestines,12639,64,0.85 [0.67-1.06],0.1532873873189209
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,15860,928,1.01 [0.95-1.08],0.6422648013910592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15030,98,1.02 [0.84-1.22],0.8681598967602352
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12670,95,0.90 [0.74-1.08],0.2513668140163467
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,18306,120,1.01 [0.85-1.19],0.9337078007710544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13003,428,0.98 [0.89-1.07],0.6529822118548472
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19711,275,1.07 [0.95-1.20],0.2526264788726286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18821,665,1.03 [0.96-1.11],0.3762833377390515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19085,929,1.00 [0.94-1.07],0.9311450315116844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,13915,186,0.87 [0.76-1.00],0.0464356212679329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,14326,597,1.01 [0.94-1.10],0.7176531691642074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19686,113,1.06 [0.89-1.26],0.5297398501189965
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15000,68,1.13 [0.89-1.43],0.3059185361177238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13734,1159,1.00 [0.94-1.05],0.8656722109275925
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18163,297,0.99 [0.89-1.10],0.8856036066154571
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17991,125,1.01 [0.85-1.19],0.9322734278265046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,14213,1638,0.97 [0.93-1.02],0.2001034807356623
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,17772,5197,0.97 [0.94-0.99],0.0108139465508633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19007,182,1.06 [0.92-1.22],0.4277678824728302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,19497,636,0.98 [0.91-1.05],0.587363747614738
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14387,658,1.00 [0.93-1.07],0.9704763377813908
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of pancreas,18040,174,0.91 [0.79-1.05],0.2015455812299654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19601,359,0.99 [0.90-1.09],0.8466095811865755
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14652,923,0.99 [0.93-1.05],0.705552239349556
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19251,1065,0.95 [0.90-1.00],0.0730599195818122
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19201,148,0.98 [0.84-1.14],0.7538790542599216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14353,1778,0.97 [0.93-1.02],0.2466694689481323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15561,1832,0.98 [0.94-1.02],0.3015243072205783
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18960,99,0.94 [0.78-1.14],0.541179627266551
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18976,820,1.00 [0.94-1.07],0.9724546361585714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12941,366,0.94 [0.85-1.03],0.1765206695085497
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19707,22,1.38 [0.90-2.10],0.1372512230928929
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13085,510,0.92 [0.84-0.99],0.034426604062329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18324,138,1.01 [0.86-1.18],0.8976037386080575
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Recurring oral aphthae,19723,43,0.74 [0.56-0.96],0.0246705573453024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19047,81,0.92 [0.75-1.13],0.4416342680179274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Toxic colitis,18227,71,0.94 [0.75-1.17],0.5798677738125846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14029,300,1.04 [0.93-1.15],0.5255977656054072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,18301,145,0.98 [0.84-1.14],0.7791928309568653
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18273,117,0.98 [0.83-1.16],0.8015943120828942
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,15150,218,0.93 [0.82-1.05],0.2365307276299788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12779,204,0.86 [0.76-0.98],0.02379706800729
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,15162,230,1.03 [0.91-1.16],0.6623921672588537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Volvulus,12650,75,0.82 [0.67-1.01],0.061887086211074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19647,352,1.04 [0.94-1.15],0.4223498121368235
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19428,60,1.04 [0.82-1.33],0.7278692327680785
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17618,142,1.04 [0.89-1.22],0.6355396794119683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19203,696,0.97 [0.91-1.04],0.4287986914670764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18628,121,1.06 [0.89-1.25],0.5317504372454329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17966,490,0.94 [0.86-1.02],0.1325679570927631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19444,263,1.04 [0.93-1.17],0.4654625413011723
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19641,460,1.00 [0.92-1.09],0.9630963882943798
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19225,44,0.91 [0.69-1.20],0.5026802397322605
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18378,3119,0.97 [0.94-1.01],0.1147623194909178
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19366,362,0.95 [0.87-1.05],0.3502129182312085
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19252,248,0.96 [0.86-1.08],0.5209662936851674
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19409,902,0.97 [0.91-1.03],0.3586302061525572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19718,49,0.91 [0.69-1.18],0.4623428117665192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17531,55,0.97 [0.76-1.25],0.8360902882864782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19058,54,0.90 [0.70-1.15],0.3987195497047434
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19432,251,1.03 [0.91-1.16],0.6478161754106665
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17978,502,0.98 [0.90-1.07],0.6643553843751877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17556,80,0.87 [0.71-1.06],0.1720581391838487
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19663,74,0.84 [0.68-1.04],0.1110531609692908
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18692,185,1.03 [0.90-1.19],0.6370857835065069
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19564,196,0.93 [0.81-1.06],0.2588035318145499
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19256,75,0.98 [0.79-1.21],0.8299036807492898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17539,63,0.88 [0.70-1.10],0.251189800962496
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19214,1738,0.98 [0.93-1.02],0.3152703316393903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18015,539,0.97 [0.89-1.05],0.4248293967380192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17559,83,0.85 [0.70-1.04],0.1139429151713956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19659,291,0.96 [0.86-1.07],0.4534272934370177
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19244,63,0.98 [0.77-1.24],0.8556487000167539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19609,241,0.97 [0.86-1.09],0.5928642282822907
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19676,381,1.03 [0.93-1.13],0.56328633202841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17581,105,0.98 [0.82-1.17],0.8141455737611347
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17758,282,0.92 [0.83-1.03],0.1554490808060182
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19664,369,1.03 [0.93-1.13],0.5989270260459294
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17746,270,1.01 [0.90-1.13],0.8943126027959514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19712,123,0.95 [0.80-1.12],0.5372328335911766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16479,68,0.94 [0.75-1.17],0.5757648711971195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17416,5444,1.01 [0.99-1.04],0.2965609941802185
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16216,4244,1.01 [0.99-1.04],0.3481525734101081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16455,44,1.01 [0.76-1.34],0.9433698902339251
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16451,117,1.00 [0.84-1.18],0.9623009103179644
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16491,157,0.96 [0.83-1.12],0.61189233057818
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19519,52,0.80 [0.62-1.03],0.080781415345283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16457,123,0.95 [0.81-1.12],0.5666008898070745
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13231,1259,1.02 [0.97-1.08],0.4641343359334217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19557,210,1.06 [0.93-1.20],0.3949839437024455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16805,471,1.02 [0.93-1.11],0.6895336672510761
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16001,6802,1.02 [0.99-1.04],0.1785240842843315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17609,103,0.92 [0.77-1.10],0.3680808437525531
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16563,152,1.00 [0.86-1.16],0.9812985067996944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16842,431,1.02 [0.93-1.12],0.6661869488087386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18940,2606,1.00 [0.97-1.04],0.8933862644562351
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16679,268,0.91 [0.81-1.02],0.0928337739834944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16533,122,1.18 [0.99-1.41],0.0604553932980863
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16512,101,1.04 [0.86-1.25],0.6890085268141739
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19079,84,0.94 [0.77-1.15],0.5319456864555774
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13667,1695,1.00 [0.96-1.05],0.8727409232802922
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12617,645,1.08 [1.01-1.17],0.0321497025655046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19650,640,1.08 [1.00-1.16],0.0418114660701658
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12034,62,0.98 [0.78-1.25],0.8984981717102818
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12235,263,0.94 [0.83-1.05],0.2542837410576641
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16633,222,0.97 [0.86-1.10],0.6418862365336844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12380,408,1.03 [0.94-1.13],0.5687885419808456
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16402,68,1.30 [1.03-1.65],0.0288431725770599
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16892,558,0.99 [0.92-1.07],0.854071670909113
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16587,253,1.02 [0.91-1.15],0.7541169818823843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12354,382,1.03 [0.93-1.13],0.6139611372233392
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16469,58,1.12 [0.87-1.44],0.3694814969155889
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16459,48,1.19 [0.90-1.57],0.2170971350284198
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17575,69,0.99 [0.79-1.23],0.906231461808752
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19374,1868,0.96 [0.92-1.01],0.0973984400516149
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18820,1314,0.96 [0.91-1.01],0.11341919645525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19593,455,1.06 [0.97-1.16],0.1853821768017302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14606,2634,1.03 [0.99-1.06],0.1676535057888825
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12009,37,0.96 [0.71-1.30],0.8074194399341688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16496,85,1.13 [0.92-1.40],0.2345172864650959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12035,63,0.95 [0.75-1.20],0.6746294560599457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12084,112,1.04 [0.87-1.24],0.6899012525518894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17711,205,0.90 [0.79-1.02],0.10086584467053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17915,409,0.94 [0.86-1.03],0.2026917468831946
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19720,92,1.22 [1.00-1.50],0.0512053863484005
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17971,1637,1.01 [0.96-1.05],0.8135806771168278
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16471,60,1.30 [1.01-1.67],0.0436395960629511
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12100,128,1.05 [0.89-1.23],0.5928227126018495
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16991,657,1.04 [0.97-1.12],0.3018984496826463
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13806,1834,1.02 [0.97-1.06],0.5040516597141651
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19101,106,0.99 [0.83-1.19],0.9492120710305516
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19728,57,1.08 [0.84-1.38],0.5591134862929139
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16479,68,1.01 [0.81-1.27],0.9097417723402358
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17538,1127,1.07 [1.01-1.13],0.0246788615538421
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16499,88,1.01 [0.83-1.23],0.9026538003863528
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13724,1752,1.03 [0.98-1.07],0.2513585950429804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17609,103,0.90 [0.75-1.08],0.2507342007761296
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16439,28,1.02 [0.71-1.45],0.9307333792117048
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16499,165,0.92 [0.80-1.07],0.2787101776760634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16981,570,1.05 [0.97-1.14],0.2021784256962616
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19411,416,1.11 [1.01-1.22],0.02927522306797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16875,541,0.95 [0.88-1.03],0.2197214445726608
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19604,450,1.06 [0.97-1.16],0.2117001494925096
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19714,54,1.35 [1.04-1.76],0.0263403794134481
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16548,137,0.94 [0.81-1.10],0.4688643725238823
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15388,724,1.02 [0.95-1.10],0.5331343492648013
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16946,535,1.03 [0.95-1.12],0.4524213598013565
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16652,241,0.91 [0.81-1.03],0.1258842822795945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12037,65,1.12 [0.89-1.42],0.3408118171978256
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14605,2633,1.04 [1.01-1.08],0.0222944053657845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12669,697,0.99 [0.92-1.07],0.8373664297283916
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19301,306,1.08 [0.97-1.21],0.1494637642086065
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19691,63,1.07 [0.84-1.35],0.6023828308351276
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17505,57,1.21 [0.93-1.56],0.1481069640616679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12030,58,1.07 [0.83-1.36],0.6148080669025504
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16424,90,1.07 [0.87-1.30],0.5259291536524977
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12434,462,1.07 [0.98-1.16],0.1489922637576783
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16696,285,1.02 [0.91-1.14],0.766566490962458
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16566,232,1.14 [1.00-1.29],0.0468847086229267
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16549,215,0.98 [0.86-1.11],0.7476879218587993
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13926,59,1.31 [1.01-1.69],0.0384477978407396
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19719,59,1.22 [0.95-1.56],0.122484244554349
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16879,468,1.03 [0.94-1.12],0.5086822958532015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19085,90,1.20 [0.98-1.47],0.0806681689186517
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18629,2218,1.04 [0.99-1.08],0.089943012879682
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16536,125,0.96 [0.82-1.14],0.6669946184738812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16903,569,1.02 [0.95-1.11],0.5458384527914133
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18548,225,0.93 [0.82-1.05],0.2210972787844023
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16532,198,1.03 [0.90-1.18],0.6510899210518679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17973,1639,1.00 [0.95-1.04],0.8984932461616271
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17408,1074,1.01 [0.96-1.07],0.6285303594599438
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16459,48,1.05 [0.80-1.38],0.7266887004891862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19102,107,1.01 [0.85-1.21],0.8865609446657805
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16554,143,1.09 [0.93-1.28],0.2713494600346297
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16491,80,0.94 [0.76-1.15],0.5321445900579569
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12035,63,1.15 [0.90-1.46],0.2552242092540234
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,18609,1783,0.99 [0.94-1.03],0.5533701413152661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7974,23,1.39 [0.91-2.10],0.124756197271582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10112,28,1.36 [0.93-1.99],0.1111970786676749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19461,262,1.07 [0.95-1.21],0.2401797127448187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19289,90,1.02 [0.84-1.24],0.8406677483909714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18546,1720,0.96 [0.92-1.00],0.0692431830932603
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19557,85,0.90 [0.74-1.10],0.2943696619146994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19508,328,0.98 [0.88-1.09],0.68872089102336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,16576,256,1.04 [0.92-1.17],0.5391527138241146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dialysis,16896,70,1.18 [0.93-1.49],0.1680271672769984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8642,1790,1.01 [0.96-1.05],0.7352921484392059
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,10192,108,1.11 [0.92-1.33],0.2695414883561899
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,7986,35,1.12 [0.81-1.55],0.5052010388649331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8434,483,1.04 [0.96-1.14],0.3426762056796981
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16307,5225,0.99 [0.97-1.02],0.4975023869019024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19536,64,0.94 [0.74-1.18],0.5798239358819461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydrocele,6952,100,0.95 [0.79-1.15],0.6021847700318178
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16850,274,1.02 [0.91-1.14],0.7441029544996555
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8373,1521,1.00 [0.96-1.05],0.9189224146924264
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10246,137,0.98 [0.84-1.16],0.8459769634457691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6953,101,0.90 [0.75-1.08],0.2663458925752646
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16389,69,1.01 [0.81-1.26],0.949695153527424
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8822,871,0.99 [0.93-1.06],0.7891923441953644
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6905,53,0.84 [0.65-1.07],0.1536482093148602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7985,34,0.76 [0.56-1.04],0.0854732766414712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19729,74,1.09 [0.88-1.36],0.4324857559892261
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19722,73,0.93 [0.75-1.15],0.4789403344600202
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18718,2398,0.98 [0.95-1.02],0.3339421051928739
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17117,797,0.95 [0.89-1.01],0.0958906858997313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10128,44,1.03 [0.78-1.37],0.8129866156699671
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19673,493,1.00 [0.92-1.08],0.9135065040127032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6973,121,1.05 [0.89-1.25],0.5638807672051737
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6984,132,1.01 [0.86-1.19],0.878061361045374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6978,126,1.05 [0.89-1.24],0.5555228335799898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19704,68,1.03 [0.82-1.30],0.779272507885593
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18189,1869,1.00 [0.96-1.04],0.9963682658095746
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10181,72,0.93 [0.75-1.16],0.5304990606785702
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8015,64,1.24 [0.97-1.60],0.0862552931715547
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8082,131,0.98 [0.83-1.15],0.7881366920467724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8000,49,0.78 [0.60-1.01],0.0627162145251287
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8038,87,0.97 [0.79-1.18],0.7410188512876166
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16900,324,1.02 [0.92-1.13],0.7750290136311305
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19340,160,1.05 [0.91-1.22],0.5114854683888874
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8053,102,1.02 [0.85-1.23],0.8282286620954629
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7973,22,0.77 [0.52-1.13],0.1792362547282766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8132,181,0.98 [0.85-1.12],0.7490958981640812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8033,82,1.18 [0.95-1.45],0.1322096595225307
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8133,182,0.95 [0.82-1.09],0.4447932688487059
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19517,45,0.85 [0.65-1.11],0.2314939774565363
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6978,126,0.94 [0.80-1.11],0.4436389186356628
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19524,2948,0.98 [0.95-1.01],0.2375357712749952
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16651,75,1.01 [0.81-1.25],0.955749110227734
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16967,141,0.99 [0.85-1.15],0.8642955230487418
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19231,32,1.06 [0.76-1.48],0.7348590183121093
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,16544,224,1.02 [0.90-1.16],0.7038395896715977
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,19537,338,1.06 [0.95-1.17],0.2940779784470622
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,7985,34,1.06 [0.76-1.49],0.7225931690440526
